EPDOX-CV 162.5 – Cefpodoxime Proxetil 100mg + Clavulanic Acid 62.5mg Dispersible Tablets

EPDOX-CV 162.5

Composition: Cefpodoxime Proxetil 100mg + Clavulanic Acid 62.5mg Dispersible Tablets

Product information

Brand
EPDOX-CV 162.5
Composition
Cefpodoxime Proxetil 100mg + Clavulanic Acid 62.5mg Dispersible Tablets
Dosage Form
Tablets
Category
Tablets
Therapeutic Range
Anti-Infectives
Pack Size
10X10 Strip

About EPDOX-CV 162.5

Epox-CV 162.5 is an antibiotic combination of Cefpodoxime Proxetil 100mg and Potassium Clavulanate 62.5mg. It is used to treat various bacterial infections, including respiratory, urinary tract, and skin infections. The combination of Cefpodoxime Proxetil (a cephalosporin antibiotic) and Potassium Clavulanate (which inhibits beta-lactamase) provides a broad-spectrum antimicrobial effect.

Composition:

  • Cefpodoxime Proxetil I.P. 100 mg

  • Potassium Clavulanate I.P. 62.5 mg

Uses:

  • Treats bacterial infections

  • Effective for respiratory infections

  • Treats urinary tract infections

  • Skin infections

Indications:

  • Community-acquired pneumonia

  • Urinary tract infections

  • Skin infections

View range

PCD pharma franchise

Get PCD franchise for EPDOX-CV 162.5

Interested in EPDOX-CV 162.5 and our complete range? Get rates, franchise terms and monopoly rights for your area.

Download Product List